Jo River1, Heather McKenzie2, David Levy3, Nick Pavlakis4, Michael Back4, Byeongsang Oh4. 1. M02, Sydney Nursing School, The University of Sydney, Sydney, NSW, 2006, Australia. jo.river@sydney.edu.au. 2. M02, Sydney Nursing School, The University of Sydney, Sydney, NSW, 2006, Australia. 3. Cancer Centre, Chris O'Brien Lifehouse, 119 Missenden Road, Camperdown, NSW, Australia. 4. Northern Sydney Cancer Centre, Level 1c, ASB, Royal North Shore Hospital, St Leonards, NSW, Australia.
Abstract
PURPOSE: Demand for complementary and alternative medicine (CAM) is high among cancer patients. This, alongside growing evidence for the efficacy of some CAM therapies, is driving change within cancer centres, where evidence-based CAM therapies are increasingly provided alongside standard cancer treatments. In Australia, commitment to equitable access to healthcare is strong, and some cancer centres are now providing integrative services at no cost to the patient. This represents a significant shift in healthcare provision. This study aimed to examine health professional and patient dynamics in an integrated cancer service where CAM is provided at no cost to patients alongside standard cancer treatments. It specifically sought to understand what might drive or hinder further integration of CAM with standard treatment in the cancer context. METHODS: Qualitative interviews were undertaken with twenty key stakeholders-cancer patients, cancer nurses, and oncologists-who were delivering or receiving care in an Australian public hospital where acupuncture services are provided at no cost to patients alongside standard chemotherapy and radiation treatments. RESULTS: Findings point to key areas where the concerns and priorities of cancer patients, cancer nurses, and oncologists converge and diverge in ways that reflect core personal and professional interests regarding patient care needs, the evidence base for CAM efficacy and safety, and rising healthcare costs. CONCLUSIONS: Understanding points of convergence and divergence could assist clinicians and service providers in negotiating ways forward for integrative cancer services.
PURPOSE: Demand for complementary and alternative medicine (CAM) is high among cancerpatients. This, alongside growing evidence for the efficacy of some CAM therapies, is driving change within cancer centres, where evidence-based CAM therapies are increasingly provided alongside standard cancer treatments. In Australia, commitment to equitable access to healthcare is strong, and some cancer centres are now providing integrative services at no cost to the patient. This represents a significant shift in healthcare provision. This study aimed to examine health professional and patient dynamics in an integrated cancer service where CAM is provided at no cost to patients alongside standard cancer treatments. It specifically sought to understand what might drive or hinder further integration of CAM with standard treatment in the cancer context. METHODS: Qualitative interviews were undertaken with twenty key stakeholders-cancerpatients, cancer nurses, and oncologists-who were delivering or receiving care in an Australian public hospital where acupuncture services are provided at no cost to patients alongside standard chemotherapy and radiation treatments. RESULTS: Findings point to key areas where the concerns and priorities of cancerpatients, cancer nurses, and oncologists converge and diverge in ways that reflect core personal and professional interests regarding patient care needs, the evidence base for CAM efficacy and safety, and rising healthcare costs. CONCLUSIONS: Understanding points of convergence and divergence could assist clinicians and service providers in negotiating ways forward for integrative cancer services.
Entities:
Keywords:
Cancer; Complementary and alternative medicine; Integrative medicine; Supportive care
Authors: Laura Weeks; Dugald Seely; Cathy DeGrasse; Shailendra Verma; Heather Boon; Marja Verhoef; Dawn Stacey Journal: Support Care Cancer Date: 2013-11-13 Impact factor: 3.603
Authors: Paul Posadzki; Tae-Woong Moon; Tae-Young Choi; Tae-Yong Park; Myeong Soo Lee; Edzard Ernst Journal: Support Care Cancer Date: 2013-02-24 Impact factor: 3.603
Authors: Elizabeth Dean-Clower; Anne M Doherty-Gilman; Aparna Keshaviah; Frank Baker; Chiewkwei Kaw; Weidong Lu; Judith Manola; Richard T Penson; Ursula A Matulonis; David S Rosenthal Journal: Integr Cancer Ther Date: 2010-06 Impact factor: 3.279
Authors: Markus Horneber; Gerd van Ackeren; Felix Fischer; Herbert Kappauf; Josef Birkmann Journal: Integr Cancer Ther Date: 2018-10-23 Impact factor: 3.279